SNPX: Synaptogenix Inc. Year-over-year net earnings per share growth for the last 12 months
Synaptogenix, Inc. (SNPX) possesses a critical dependency on a single molecule, which creates high binary risks. Exclusive patents on the therapy serve as a safeguard, despite stringent FDA oversight. The quarterly EPS history in the GURU.Markets terminal provides a chart of the metric, where the value remains at 0.00, confirming the company's commitment to restoring patients' cognitive functions through the activation of protein kinase C.
Analytical breakdowns for Synaptogenix, Inc.
- market value and analyst target forecast:
- market capitalization information:
- book capitalization indicators:
- company total debt and liquidity indicators:
Total Debt to Capital Synaptogenix, Inc.|SNPX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Synaptogenix, Inc.|SNPX - Company Aggregate Debt|Debts to Book Capitalization Neurotrope|SNPX - Long-Term Debt Volume|Company Current Liabilities Synaptogenix|Quick Liquidity Indicator synaptogen.com
- earnings and market multiples details:
SNPX - Final Profit|Projected Future Earnings Synaptogenix, Inc.|SNPX - Business Payback Period|Future Price to Earnings Neurotrope|SNPX - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Neurotrope|SNPX - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Synaptogenix|SNPX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months synaptogen.com|SNPX - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Synaptogenix, Inc.
- sales volume and revenue indicators:
Summary company analysis:Synaptogenix - SNPX
This indicator measures the dynamics of net earnings per share, allowing for an assessment of asset monetization efficiency and the growth rate of quarterly operating returns. By analyzing the magnitude of quarterly EPS growth, an investor can forecast the financial stability of Synaptogenix, Inc. (SNPX) against the backdrop of development costs for Briostatin-1 and market demand for innovative Alzheimer's disease therapies.
Competitors of Synaptogenix, Inc. (SNPX)
Biogen (BIIB) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months NBIX (Neurocrine)|Year-over-year net earnings per share growth for the last 12 months RGC|AXSM (Axsome Corp) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months ACADIA Pharmaceuticals (ACAD)|XENE - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth VKTX (Viking Therapeutics, Inc.)|Net earnings per share growth for the trailing year Supernus Pharmaceuticals, Inc.|Catalyst Pharmaceuticals Inc - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Denali Corp|Harmony Biosciences (HRMY) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months BHVN|AMLX (Amylyx Pharmaceuticals, Inc.) - Quarterly EPS earnings growth|Trevi Therapeutics Inc (TRVI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months PRAX (Praxis Medicines)|Anavex Life Sciences Corp - Year-over-year earnings per share growth for the last 12 months|CeriBell, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PRTA|Alector Therapeutics - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Annexon Biosciences ANNX|omeros.com (OMER) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months NGNE|ACIU (AC Immune) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months voyagertherapeutics.com (VYGR)|Year-over-year net earnings per share growth for the last 12 months NMRA (Neumora Therapeutics, Inc.)|Year-over-year net earnings per share change for the last twelve months Scilex Holding|Year-over-year earnings per share growth for the last twelve months Tevogen Bio Holdings, Inc. TVGN|Year-over-year net earnings per share change for the last twelve months Alpha Cognition Inc (ACOG)|CGTX - Year-over-year earnings per share growth for the last twelve months|IKT (inhibikase.com) - Year-over-year earnings per share growth for the last 12 months|Cassava Sciences (SAVA) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ASRT (Assertio)|Year-over-year net earnings per share growth for the last 12 months COYA|Year-over-year earnings per share growth for the last 12 months VTGN (VistaGen Therapeutics Inc)|Year-over-year earnings per share growth for the last twelve months Ovid Therapeutics Inc. (OVID)|acumenpharm.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth CRVO (CervoMed)|Alterity Therapeutics Ltd. (ATHE) - Earnings per share growth in annualized terms for the last twelve months|CLNN: Year-over-year net earnings per share growth for the last 12 months|PEPG - Quarterly EPS earnings growth|Jupiter Neurosciences (JUNS) - Year-over-year earnings per share growth for the last twelve months|relmada.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Annovis Bio|Earnings per share growth in annualized terms for the last twelve months Grace Tx GRCE|Year-over-year earnings per share growth for the last twelve months Firefly Neuroscience Inc (AIFF)|Year-over-year net earnings per share change for the last twelve months anewmeds.com|NeuroSense Therapeutics Ltd. - Year-over-year net earnings per share growth for the last 12 months|revivapharma.com (RVPH) - Earnings per share growth in annualized terms for the last twelve months|MTVA - Year-over-year earnings per share growth for the last twelve months|NRXS (NeurAxis Inc.) - Year-over-year earnings per share growth for the last 12 months|HSDT: Quarterly EPS earnings growth|Passage Bio (PASG) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Year-over-year net earnings per share trend for the last twelve months|Year-over-year net earnings per share growth for the last 12 months ATHA (Athira Pharma)|Year-over-year earnings per share growth rate for the last twelve months ADXN|Year-over-year earnings per share growth for the last twelve months Alzamend Neuro ALZN|Cyclerion Therapeutics Inc. (CYCN) - Earnings per share growth in annualized terms for the last twelve months|Protagenic - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year Pasithea Therapeutics (KTTA)|CRGT: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Avenue Therapeutics Inc. (ATXI)|Year-over-year earnings per share growth for the last twelve months Brainstorm Cell Therapeutics, Inc.|Year-over-year earnings per share growth for the last 12 months CARA (Cara Therapeutics Inc)|Quarterly EPS earnings growth CHRO|Year-over-year net earnings per share change for the last twelve months eliemtx.com|Intra-Cellular Therapies, Inc. - Year-over-year net earnings per share growth for the last 12 months|LBPH: Year-over-year earnings per share growth for the last 12 months|MRNS: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months NKGN (NKGen Biotech Corp)|NRBO: Quarterly EPS earnings growth|SAGE - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Trevena|Year-over-year earnings per share growth for the last 12 months VIGL (Vigil Neuro)|Quarterly EPS earnings growth WENA|Year-over-year net earnings per share growth for the last 12 months Cerevel Corp CERE
